Carregant...
PATH-39. A NEW MOLECULAR PROGNOSTIC MARKER FOR MALIGNANT GLIOMA
Glioma is the most popular primary CNS tumor and especially, Glioblastoma multiforme (GBM), WHO Grade IV glioma, is the worst prognostic tumor in all systemic cancers. Despite maximum resection followed by chemoradiotherapy, the overall median survival is only about 15 months. To date, molecular res...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692468/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.729 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|